As briefly mentioned in our article last week on Priority Review Vouchers, the financial terms of a biopharma patent licence agreement...

The licensing of content for AI model training is on the rise. Amid reports that developers are facing a scarcity of content to train AI...

On 5 November 2024, Acadia Pharmaceuticals Inc. ("Acadia") announced that it sold its rare paediatric disease priority review voucher...

In this episode, Camille Beckmann speaks to Anneke Pol and Vik Khurana (along with a special guest AI chatbot!) on how to structure...

On 24 October 2024, Cancer Research UK ("CRUK") and KisoJi Biotechnology Inc. ("KBI") announced that they have entered into an agreement...

Reports abound in the media about AI companies entering into licensing deals with organisations including media organisations and other...

A recent report from Sporting Intelligence estimates that Premier League clubs have collectively earned over £1bn for the 2024-25 season...

Vertex Pharmaceuticals announced a reimbursement agreement with NHS England for individuals 12 years or older with transfusion-dependent...

It's hard to believe that six months have passed since we released the 11th edition of our Biotech Review of the Year publication. Our...

Sponsorship revenues are fundamental to the very existence of sports clubs at all levels. They are undoubtedly among the biggest income...

Bristows was delighted to sponsor and attend this year’s EU Pharmaceutical Law Forum, which was held in Brussels at the Steigenberger...

Cell and gene therapies (CGTs) continue to hold considerable promise for the future of medicine, providing unprecedented therapeutic...